Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
3.185
-0.145 (-4.35%)
At close: Nov 13, 2026, 4:00 PM EST
3.100
-0.085 (-2.67%)
Pre-market: Nov 16, 2026, 8:55 AM EST

Recursion Pharmaceuticals Revenue

Recursion Pharmaceuticals had revenue of $18.55M in the quarter ending September 30, 2026, with 258.49% growth. This brings the company's total for the last twelve months to $68.23M, up 56.18% year-over-year. In the year 2025, Recursion Pharmaceuticals had annual revenue of $74.68M with 26.92% growth. That makes Recursion Pharmaceuticals the 25,653rd largest company in the world by revenue and 3,553rd in the United States.

Revenue (ttm)
$68.23M
Revenue Growth
+56.18%
P/S Ratio
29.10
Revenue / Employee
$113,720
Employees
600
Market Cap
1.99B

Revenue Chart

Revenue by Segment

By Segment

Chart
  • Research and Development Agreements 74.26M 99.4%
  • Grant 425.00K 0.6%

By Geography

Chart
  • United States 39.34M 52.7%
  • United Kingdom 35.34M 47.3%

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202574.68M15.84M26.92%
Dec 31, 202458.84M14.26M32.00%
Dec 31, 202344.58M4.73M11.88%
Dec 31, 202239.84M29.67M291.46%
Dec 31, 202110.18M6.22M156.89%
Dec 31, 20203.96M1.64M70.85%
Dec 31, 20192.32M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.